CD274 and neoplasm: The second mechanism is induction of PD-L1 expression, not constitutively, but rather in response to inflammatory cytokines, in particular, interferon-γ [17], representing an adaptation of tumor cells to a “hostile” inflammatory ME, referred to as immune adaptive resistance [16].